
| ROI Name | ∑ In  | % In  | log ratio  | ∑ Out  | % Out  | 
|---|---|---|---|---|---|
| LH_L | 38 | 8.7% | 4.38 | 793 | 56.4% | 
| AL_L | 386 | 88.1% | -0.01 | 384 | 27.3% | 
| MB_CA_L | 6 | 1.4% | 5.23 | 225 | 16.0% | 
| CRE_L | 2 | 0.5% | 0.58 | 3 | 0.2% | 
| SCL_L | 3 | 0.7% | -inf | 0 | 0.0% | 
| FB | 1 | 0.2% | -inf | 0 | 0.0% | 
| ICL_L | 1 | 0.2% | -inf | 0 | 0.0% | 
| LAL_L | 1 | 0.2% | -inf | 0 | 0.0% | 
| upstream partner  | # | NT | conns M_adPNm7  | % In  | CV | 
|---|---|---|---|---|---|
| DP1l_adPN (L) | 1 | ACh | 55 | 13.6% | 0.0 | 
| ORN_VL2p (L) | 13 | ACh | 47 | 11.6% | 0.8 | 
| ORN_VL2a (L) | 17 | ACh | 27 | 6.7% | 0.5 | 
| ORN_DP1l (L) | 9 | ACh | 22 | 5.4% | 0.6 | 
| DL2d_adPN (L) | 4 | ACh | 18 | 4.5% | 0.6 | 
| VL2a_adPN (L) | 1 | ACh | 15 | 3.7% | 0.0 | 
| M_adPNm7 (L) | 1 | ACh | 15 | 3.7% | 0.0 | 
| ALIN5 (R) | 1 | GABA | 12 | 3.0% | 0.0 | 
| lLN2X02 (L) | 3 | GABA | 12 | 3.0% | 0.7 | 
| lLN1_bc (L) | 9 | Unk | 12 | 3.0% | 0.5 | 
| lLN2X04 (L) | 2 | GABA | 11 | 2.7% | 0.1 | 
| CB1546 (L) | 3 | GABA | 9 | 2.2% | 0.5 | 
| ORN_DL2d (L) | 3 | ACh | 9 | 2.2% | 0.5 | 
| v2LN30 (L) | 1 | Unk | 7 | 1.7% | 0.0 | 
| PPL202 (L) | 1 | DA | 7 | 1.7% | 0.0 | 
| v2LN31 (L) | 1 | Glu | 6 | 1.5% | 0.0 | 
| VL2p_adPN (L) | 1 | ACh | 6 | 1.5% | 0.0 | 
| lLN2P_c (L) | 1 | GABA | 6 | 1.5% | 0.0 | 
| M_adPNm8 (L) | 2 | ACh | 6 | 1.5% | 0.7 | 
| LHPV2a1_c (L) | 3 | GABA | 6 | 1.5% | 0.7 | 
| M_l2PNl20 (L) | 1 | ACh | 5 | 1.2% | 0.0 | 
| v2LNX01 (L) | 1 | Glu | 4 | 1.0% | 0.0 | 
| lLN2X12 (L) | 3 | ACh | 4 | 1.0% | 0.4 | 
| M_vPNml63 (L) | 1 | GABA | 3 | 0.7% | 0.0 | 
| lLN2F_b (L) | 1 | GABA | 3 | 0.7% | 0.0 | 
| M_vPNml72 (L) | 1 | GABA | 3 | 0.7% | 0.0 | 
| M_l2PNl20 (R) | 1 | ACh | 3 | 0.7% | 0.0 | 
| LN60b (L) | 1 | GABA | 3 | 0.7% | 0.0 | 
| il3LN6 (R) | 1 | Unk | 3 | 0.7% | 0.0 | 
| lLN2X11 (L) | 2 | 5-HT | 3 | 0.7% | 0.3 | 
| lLN2F_a (L) | 2 | GABA | 3 | 0.7% | 0.3 | 
| lLN2T_d (L) | 2 | GABA | 3 | 0.7% | 0.3 | 
| lLN2T_c (L) | 2 | 5-HT | 3 | 0.7% | 0.3 | 
| ALIN1 (R) | 2 | Unk | 3 | 0.7% | 0.3 | 
| lLN2X06 (L) | 1 | Unk | 2 | 0.5% | 0.0 | 
| v2LN3A1_b (L) | 1 | ACh | 2 | 0.5% | 0.0 | 
| CB1132 (L) | 1 | GABA | 2 | 0.5% | 0.0 | 
| lLN2X09 (L) | 1 | ACh | 2 | 0.5% | 0.0 | 
| ALBN1 (R) | 1 | Unk | 2 | 0.5% | 0.0 | 
| lLN2T_b (L) | 1 | Unk | 2 | 0.5% | 0.0 | 
| VP1m+VP2_lvPN1 (L) | 1 | ACh | 2 | 0.5% | 0.0 | 
| ORN_DP1m (L) | 1 | ACh | 2 | 0.5% | 0.0 | 
| ALIN1 (L) | 2 | Glu | 2 | 0.5% | 0.0 | 
| M_adPNm5 (L) | 2 | ACh | 2 | 0.5% | 0.0 | 
| ORN_DL2d (R) | 2 | ACh | 2 | 0.5% | 0.0 | 
| LHCENT5 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| LHPV7a1a (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| OA-VUMa2 (M) | 1 | OA | 1 | 0.2% | 0.0 | 
| LHAV3f1 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| LHPV12a1 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| D_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| DNp30 (R) | 1 | 5-HT | 1 | 0.2% | 0.0 | 
| lLN2X07 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| il3LN6 (L) | 1 | Unk | 1 | 0.2% | 0.0 | 
| M_lvPNm25 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| lLN1_a (L) | 1 | 5-HT | 1 | 0.2% | 0.0 | 
| ORN_VM6l (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| SLP438 (L) | 1 | DA | 1 | 0.2% | 0.0 | 
| VA1v_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB0244 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| ORN_DL2v (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| OA-VUMa5 (M) | 1 | OA | 1 | 0.2% | 0.0 | 
| V_ilPN (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| VP1d_il2PN (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB1266 (L) | 1 | Unk | 1 | 0.2% | 0.0 | 
| ORN_DP1l (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| DP1m_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| VL1_ilPN (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| LHPV4a1 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| CB1518 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| lLN2P_b (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| lLN2X10 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB1513 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| downstream partner  | # | NT | conns M_adPNm7  | % Out  | CV | 
|---|---|---|---|---|---|
| KCg-m (L) | 6 | ACh | 115 | 18.5% | 0.2 | 
| LHAV2b2a (L) | 5 | ACh | 37 | 5.9% | 0.8 | 
| CB1182 (L) | 2 | ACh | 32 | 5.1% | 0.3 | 
| mALB3 (R) | 2 | GABA | 19 | 3.0% | 0.1 | 
| LHAD1b2_a,LHAD1b2_c (L) | 5 | ACh | 18 | 2.9% | 0.7 | 
| VP2_l2PN (L) | 1 | ACh | 17 | 2.7% | 0.0 | 
| PPL202 (L) | 1 | DA | 16 | 2.6% | 0.0 | 
| LHPV2a1_c (L) | 3 | GABA | 16 | 2.6% | 0.9 | 
| KCapbp-ap2 (L) | 1 | ACh | 15 | 2.4% | 0.0 | 
| M_adPNm7 (L) | 1 | ACh | 15 | 2.4% | 0.0 | 
| CB3110 (L) | 3 | ACh | 15 | 2.4% | 0.8 | 
| LHCENT3 (L) | 1 | GABA | 14 | 2.2% | 0.0 | 
| DNb05 (L) | 1 | ACh | 13 | 2.1% | 0.0 | 
| LHPV10b1 (L) | 1 | ACh | 13 | 2.1% | 0.0 | 
| LHAV2b2b (L) | 1 | ACh | 12 | 1.9% | 0.0 | 
| M_l2PN3t18 (L) | 2 | ACh | 11 | 1.8% | 0.6 | 
| LHPV2g1 (L) | 1 | ACh | 10 | 1.6% | 0.0 | 
| ALBN1 (L) | 1 | Glu | 8 | 1.3% | 0.0 | 
| M_vPNml72 (L) | 1 | GABA | 7 | 1.1% | 0.0 | 
| CB1381 (L) | 1 | Unk | 7 | 1.1% | 0.0 | 
| CB1244 (L) | 2 | ACh | 7 | 1.1% | 0.4 | 
| LHPV2a1_a (L) | 1 | GABA | 6 | 1.0% | 0.0 | 
| LHAD1f2 (L) | 1 | Glu | 6 | 1.0% | 0.0 | 
| CB3036 (L) | 2 | GABA | 6 | 1.0% | 0.7 | 
| CB2561 (L) | 1 | GABA | 5 | 0.8% | 0.0 | 
| CB3780 (L) | 1 | ACh | 5 | 0.8% | 0.0 | 
| LHPV2a1_d (L) | 2 | GABA | 5 | 0.8% | 0.6 | 
| M_vPNml65 (L) | 2 | GABA | 5 | 0.8% | 0.6 | 
| M_adPNm8 (L) | 2 | ACh | 5 | 0.8% | 0.2 | 
| CB2111 (L) | 1 | Glu | 4 | 0.6% | 0.0 | 
| WEDPN4 (L) | 1 | GABA | 4 | 0.6% | 0.0 | 
| LHPV5b4 (L) | 1 | ACh | 4 | 0.6% | 0.0 | 
| LHAV5d1 (L) | 1 | ACh | 4 | 0.6% | 0.0 | 
| M_l2PNm16 (L) | 2 | ACh | 4 | 0.6% | 0.5 | 
| LHPV7a1a (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| v2LN30 (L) | 1 | Unk | 3 | 0.5% | 0.0 | 
| CB2725 (L) | 1 | Glu | 3 | 0.5% | 0.0 | 
| LHPV4a1 (L) | 1 | Glu | 3 | 0.5% | 0.0 | 
| M_adPNm6 (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| LHPV5a1 (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| CB1241 (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| LHAV2k13 (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| M_vPNml63 (L) | 1 | GABA | 3 | 0.5% | 0.0 | 
| CB3212 (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| LHAV2b7_a (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| M_l2PN10t19a (L) | 1 | ACh | 3 | 0.5% | 0.0 | 
| CB2135 (L) | 2 | Glu | 3 | 0.5% | 0.3 | 
| CB1793 (L) | 1 | Unk | 2 | 0.3% | 0.0 | 
| DP1l_adPN (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| ALON1 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| M_lvPNm24 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| LHPD5a1 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| LHPV12a1 (L) | 1 | GABA | 2 | 0.3% | 0.0 | 
| LHAV2k8 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| CB3131 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| SLP270 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| vLN27 (L) | 1 | Unk | 2 | 0.3% | 0.0 | 
| LHAV4a2 (L) | 1 | GABA | 2 | 0.3% | 0.0 | 
| lLN2F_b (L) | 1 | GABA | 2 | 0.3% | 0.0 | 
| M_vPNml51 (L) | 1 | GABA | 2 | 0.3% | 0.0 | 
| M_l2PNl20 (R) | 1 | ACh | 2 | 0.3% | 0.0 | 
| CB3774 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| VP2+VC5_l2PN (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| V_ilPN (R) | 1 | ACh | 2 | 0.3% | 0.0 | 
| CL077 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| CB2038 (L) | 1 | Glu | 2 | 0.3% | 0.0 | 
| ORN_VM6m (R) | 1 | GABA | 2 | 0.3% | 0.0 | 
| lLN2T_c (L) | 1 | 5-HT | 2 | 0.3% | 0.0 | 
| CB0683 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| LHAV6b1 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| M_l2PNl20 (L) | 1 | ACh | 2 | 0.3% | 0.0 | 
| CB2296 (L) | 2 | ACh | 2 | 0.3% | 0.0 | 
| lLN2X12 (L) | 2 | Unk | 2 | 0.3% | 0.0 | 
| M_lvPNm48 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| v2LN46a (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| lLN2F_a (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| AL-AST1 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| LHPV6g1 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| LHPV4a8 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| CB2549 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| VP1m+_lvPN (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| LHPV2c2b (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| LHPV5b2 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB1405 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| CB1943 (L) | 1 | Unk | 1 | 0.2% | 0.0 | 
| M_vPNml50 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| CB1266 (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| LHAD1f3a (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| CB2151 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| v2LN46b (R) | 1 | Glu | 1 | 0.2% | 0.0 | 
| M_vPNml79 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| CB1117 (L) | 1 | Unk | 1 | 0.2% | 0.0 | 
| CB1308 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| M_adPNm5 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| lLN2X04 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| CB3304 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB0997 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| LHAD1f3b (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| v2LN42b (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| LHPV6h1 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| lLN2T_d (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| LHPV4a2 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| v2LN3A1_b (L) | 1 | Unk | 1 | 0.2% | 0.0 | 
| VP1d+VP4_l2PN1 (R) | 1 | ACh | 1 | 0.2% | 0.0 | 
| VL1_vPN (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| VES013 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| LHPV5b3 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB2493 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| LHAV2g1b (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB1870 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB1661 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| DNp30 (L) | 1 | 5-HT | 1 | 0.2% | 0.0 | 
| VL2a_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB2419 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| LHAV2g2_b (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB2161 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB3040 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| LHPV7a1b (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| vLN25 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| DL2d_vPN (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| CB2277 (L) | 1 | Glu | 1 | 0.2% | 0.0 | 
| M_vPNml52 (L) | 1 | GABA | 1 | 0.2% | 0.0 | 
| VP2+_adPN (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| M_l2PNl22 (L) | 1 | ACh | 1 | 0.2% | 0.0 | 
| CB3061 (L) | 1 | Glu | 1 | 0.2% | 0.0 |